Home » Topics » Science » New compound

New compound
RSS

British scientists describe novel therapeutic approach to HIV

Feb. 3, 1997

PMPA prodrug selected as clinical candidate

Feb. 3, 1997

Anti-HIV agent that targets NCp7 zing fingers

Feb. 3, 1997

Gilead selects GS-930 prodrug for further evaluation

Feb. 3, 1997

Novel series with anti-HIV and antimalarial activity

Feb. 3, 1997

Aronex describes anti-HCMV compound

Feb. 3, 1997

Cel-Sci presents results with heteroconjugate technology for HIV vaccine development

Jan. 31, 1997

NCI discloses anti-HIV agent with novel mechanism of action

Jan. 31, 1997

Abbott develops protease inhibitor for combination therapy

Jan. 31, 1997

New NNRTI described for combination therapy

Jan. 31, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...
Circulating sncRNA transcriptome in diabetic kidney disease and SGLT2 inhibitor treatment
BioWorld Science
Small noncoding RNAs (sncRNAs), including miRNAs, piRNAs and snoRNAs, can provide further biological insights into the mechanisms of chronic kidney disease (CKD)...